Medicines Marketed by Bayer Pharmaceuticals pvt Ltd

About Bayer Pharmaceuticals pvt Ltd

Bayer Pharmaceuticals is a division of Bayer AG, a global life science company with a rich history dating back to 1863. The pharmaceutical division has evolved through various restructurings and acquisitions, solidifying its current structure after the spin-off of Bayer's materials science division, Covestro, in 2015. Based in Leverkusen, North Rhine-Westphalia, Germany, Bayer Pharmaceuticals has a strong global presence, operating through subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East.

Serving a diverse and widespread consumer base, Bayer Pharmaceuticals markets its products through wholesalers, pharmacies, hospitals, and retailers worldwide. The company caters to both healthcare professionals and patients globally, providing a wide range of prescription products in various therapeutic areas, including women's health, cardiology, oncology, haematology, ophthalmology, and radiology.

Bayer Pharmaceuticals pvt Ltd Products

Bayer Pharmaceuticals focuses on the development, manufacturing, and commercialisation of high-quality prescription products. The company's portfolio includes well-known medicines such as Xarelto, an anticoagulant used to prevent and treat blood clots; Yaz and Yasmin, birth control pills that also treat premenstrual dysphoric disorder (PMDD) and moderate acne; Nexavar, a cancer drug for the treatment of renal cell carcinoma and hepatocellular carcinoma; Betaferon/Betaseron, a treatment for multiple sclerosis; and Kogenate, a blood-clotting drug for patients with haemophilia A.

Bayer Pharmaceuticals is committed to advancing healthcare through robust research and development efforts, participating in public-private partnerships to drive innovation in drug development and safety assessments. The company's acquisition of Noria Therapeutics Inc. and PSMA Therapeutics Inc. has expanded its portfolio to include cutting-edge cancer treatments based on actinium-225. With a focus on life sciences and a diverse portfolio of prescription and specialty pharmaceuticals, Bayer Pharmaceuticals is well-positioned to meet the evolving healthcare needs of patients worldwide, ensuring broad accessibility through various distribution channels.